health
Tuning toxin activity improved immunotoxin selectivity in preclinical study
A bioRxiv preprint reports that reducing the catalytic activity of immunotoxin payloads improved selectivity between receptor-high and receptor-low cells. In an in vivo HER2-targeted test, the attenuated version had a 400-fold higher maximum tolerated dose than its wild-type counterpart.